Stock MDT MEDTRONIC PLC
Add to a list
To use this feature you must be a member
Log inSign up

Financials Medtronic plc

Equities

MDT

IE00BTN1Y115

Medical Equipment, Supplies & Distribution

Market Closed - Nyse
Other stock markets
 04:00:02 2024-04-26 pm EDT 		5-day change 1st Jan Change
79.74 USD +0.62% Intraday chart for Medtronic plc +0.33% -3.20%
Apr. 26 Medtronic Receives FDA Approval for Inceptiv Spinal Cord Stimulator to Treat Chronic Pain MT
Apr. 26 Medtronic Gets FDA OK for Inceptiv Closed-Loop Spinal Cord Stimulator DJ

Valuation

Fiscal Period: April 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 117,150 131,390 176,867 143,746 121,002 105,881 - -
Enterprise Value (EV) 1 132,626 152,047 199,663 164,146 143,823 128,179 126,950 125,501
P/E ratio 25.6 x 27.7 x 49.3 x 28.7 x 32.3 x 22.8 x 19.7 x 18.2 x
Yield 2.29% 2.37% 1.77% 2.54% 2.99% 3.45% 3.63% 3.81%
Capitalization / Revenue 3.83 x 4.54 x 5.87 x 4.54 x 3.87 x 3.28 x 3.15 x 3 x
EV / Revenue 4.34 x 5.26 x 6.63 x 5.18 x 4.61 x 3.98 x 3.78 x 3.56 x
EV / EBITDA 13.6 x 17.9 x 24.7 x 16.7 x 15.5 x 14.2 x 13.4 x 12.3 x
EV / FCF 22.6 x 25.3 x 40.9 x 27.5 x 31.4 x 22.5 x 21.4 x 18.4 x
FCF Yield 4.43% 3.96% 2.45% 3.64% 3.18% 4.45% 4.68% 5.45%
Price to Book 2.35 x 2.59 x 3.43 x 2.71 x 2.35 x 2.04 x 2 x 1.95 x
Nbr of stocks (in thousands) 1,341,151 1,340,166 1,348,073 1,341,539 1,330,424 1,327,823 - -
Reference price 2 87.35 98.04 131.2 107.2 90.95 79.74 79.74 79.74
Announcement Date 5/23/19 5/21/20 5/27/21 5/26/22 5/25/23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: April 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 30,557 28,913 30,117 31,686 31,227 32,237 33,568 35,247
EBITDA 1 9,767 8,472 8,096 9,830 9,294 9,022 9,474 10,229
EBIT 1 8,872 7,565 7,177 8,856 8,295 8,258 8,693 9,313
Operating Margin 29.03% 26.16% 23.83% 27.95% 26.56% 25.62% 25.9% 26.42%
Earnings before Tax (EBT) 1 5,197 4,055 3,895 5,517 5,364 5,511 6,154 6,566
Net income 1 4,631 4,789 3,606 5,039 3,758 4,552 5,235 5,683
Net margin 15.16% 16.56% 11.97% 15.9% 12.03% 14.12% 15.6% 16.12%
EPS 2 3.410 3.540 2.660 3.730 2.820 3.501 4.041 4.390
Free Cash Flow 1 5,873 6,021 4,885 5,978 4,580 5,703 5,942 6,838
FCF margin 19.22% 20.82% 16.22% 18.87% 14.67% 17.69% 17.7% 19.4%
FCF Conversion (EBITDA) 60.13% 71.07% 60.34% 60.81% 49.28% 63.21% 62.71% 66.85%
FCF Conversion (Net income) 126.82% 125.73% 135.47% 118.63% 121.87% 125.28% 113.49% 120.33%
Dividend per Share 2 2.000 2.320 2.320 2.720 2.720 2.753 2.894 3.037
Announcement Date 5/23/19 5/21/20 5/27/21 5/26/22 5/25/23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: April 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales 1 7,847 7,763 8,089 7,371 7,585 7,727 8,544 7,702 7,984 8,089 8,442 8,000 8,301 8,425 8,852
EBITDA 1 2,361 2,421 2,655 2,010 2,275 2,255 2,768 2,152 2,256 2,691 2,582 2,235 2,349 2,419 2,702
EBIT 1 2,116 2,181 2,402 1,765 2,020 1,998 2,512 1,909 2,009 2,042 2,301 1,993 2,107 2,166 2,456
Operating Margin 26.97% 28.09% 29.69% 23.95% 26.63% 25.86% 29.4% 24.79% 25.16% 25.24% 27.26% 24.91% 25.38% 25.71% 27.75%
Earnings before Tax (EBT) 1 - 1,589 1,602 1,044 1,395 1,375 1,551 1,196 1,313 1,472 1,476 1,233 1,392 1,431 1,743
Net income 1 1,311 1,480 1,485 929 427 1,222 1,179 791 909 1,322 1,384 1,164 1,268 1,330 1,578
Net margin 16.71% 19.06% 18.36% 12.6% 5.63% 15.81% 13.8% 10.27% 11.39% 16.34% 16.39% 14.56% 15.28% 15.79% 17.83%
EPS 2 0.9700 1.100 1.100 0.7000 0.3200 0.9200 0.8800 0.5900 0.6800 0.9900 1.070 0.8860 0.9577 1.002 1.184
Dividend per Share 2 0.6300 0.6300 0.6800 0.6800 0.6800 0.6800 0.6800 0.6900 0.6900 0.6800 0.6880 0.7171 0.7170 0.7169 0.7146
Announcement Date 11/23/21 2/22/22 5/26/22 8/23/22 11/22/22 2/21/23 5/25/23 8/22/23 11/21/23 2/20/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: April 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 15,476 20,657 22,796 20,400 22,821 22,298 21,070 19,620
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 1.585 x 2.438 x 2.816 x 2.075 x 2.455 x 2.472 x 2.224 x 1.918 x
Free Cash Flow 1 5,873 6,021 4,885 5,978 4,580 5,703 5,942 6,838
ROE (net income / shareholders' equity) 14.1% 12.3% 11.8% 14.4% 13.5% 13.3% 13.6% 14.2%
ROA (Net income/ Total Assets) 7.83% 6.88% 6.54% 5.48% 7.74% 6.53% 6.81% 7.36%
Assets 1 59,149 69,598 55,178 92,031 48,523 69,675 76,932 77,202
Book Value Per Share 2 37.20 37.80 38.20 39.50 38.70 39.10 39.80 40.80
Cash Flow per Share 2 5.160 5.350 4.610 5.440 4.530 5.360 6.410 6.990
Capex 1 1,134 1,213 1,355 1,368 1,459 1,534 1,608 1,678
Capex / Sales 3.71% 4.2% 4.5% 4.32% 4.67% 4.76% 4.79% 4.76%
Announcement Date 5/23/19 5/21/20 5/27/21 5/26/22 5/25/23 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
79.74 USD
Average target price
94.75 USD
Spread / Average Target
+18.82%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
MEDTRONIC PLC Stock Medtronic plc
-3.20% 106B
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.31% 187B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.04% 66.9B
DEXCOM, INC. Stock DexCom, Inc.
+0.20% 49.45B
CENCORA, INC. Stock Cencora, Inc.
+17.29% 48B
HOYA CORPORATION Stock Hoya Corporation
+4.06% 40.84B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+2.36% 26.25B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+2.07% 26.48B
TERUMO CORPORATION Stock Terumo Corporation
+12.96% 24.62B
ZIMMER BIOMET HOLDINGS, INC. Stock Zimmer Biomet Holdings, Inc.
-1.93% 24.52B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. MDT Stock
  4. Financials Medtronic plc